Stem-like ovarian cancer cells can serve as tumor vascular progenitors

Stem Cells

Volumn 27, Issue 10, 2009, Pages 2405-2413

  Alvero, Ayesha B ^a   Fu, Han Hsuan ^a   Holmberg, Jennie ^a   Visintin, Irene ^a   Mor, Liora ^a   Marquina, Carlos Cano ^a   Oidtman, Jessica ^a   Silasi, Dan Arin ^a   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Differentiation; Ovarian cancer; Stem cells

Indexed keywords

CD34 ANTIGEN; I KAPPA B KINASE BETA; MATRIGEL; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL SUBPOPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OVARY CANCER; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; BIOLOGICAL MARKERS; BLOOD VESSELS; CADHERINS; CARCINOMA; ENDOTHELIAL CELLS; FEMALE; HUMANS; I-KAPPA B KINASE; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 70350243076     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.191     Document Type: Article

References (29)

1. Sato Y. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy. Int J Clin Oncol 2003;8:200-206. (Pubitemid 37122254)
2. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
3. Rafii S. Circulating endothelial precursors: Mystery, reality, and promise. J Clin Invest 2000;105:17-19. (Pubitemid 30036383)
4. Goh PP, Sze DM, Roufogalis BD. Molecular and cellular regulators of cancer angiogenesis. Curr Cancer Drug Targets 2007;7:743-758.
5. Cao Y. Tumor angiogenesis and molecular targets for therapy. Front Biosci 2009;14:3962-3973.
6. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: Models and concepts. Annu Rev Med 2007;58:267-284. (Pubitemid 46706514)
7. Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-9344.
8. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967. (Pubitemid 27087709)
9. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, Mor G. Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemoresistance. Cell Cycle 2009;8: 158-166.
10. Kamsteeg M, Rutherford T, Sapi E et al. Phenoxodiol - an isoflavone analog - induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 2003;22:2611-2620. (Pubitemid 36605609)
11. Flick MB, O'Malley D, Rutherford T et al. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients. J Soc Gynecol Investig 2004;11:252-259. (Pubitemid 38561371)
12. Aldo PB, Krikun G, Visintin I et al. A novel three-dimensional in vitro system to study trophoblast-endothelium cell interactions. Am J Reprod Immunol 2007;58:98-110. (Pubitemid 47097376)
13. Alvero AB, O'Malley D, Brown D et al. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 2006;106:599-608. (Pubitemid 43157623)
14. Kelly MG, Alvero AB, Chen R et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006;66:3859-3868.
15. Chen R, Alvero AB, Silasi DA et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008;27:4712-4723.
16. Alvero AB, Chen R, Fu HH et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 2009;8:158-166.
17. Kubota Y, Kleinman HK, Martin GR et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1988;107: 1589-1598.
18. Krikun G, Mor G, Alvero A et al. A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 2004;145:2291-2296. (Pubitemid 38535058)
19. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958. (Pubitemid 30062717)
20. Venkatesha S, Toporsian M, Lam C et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-649. (Pubitemid 43865232)
21. Lee DF, Kuo HP, Chen CT et al. IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007;130:440-455.
22. Folkman J, Hanahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991;22:339-347.
23. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364. (Pubitemid 26272076)
24. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-410.
25. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
26. Bot PT, Hoefer IE, Piek JJ et al. Hyaluronic acid: Targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr Med Chem 2008;15:786-791.
27. Shen R, Ye Y, Chen L et al. Precancerous stem cells can serve as tumor vasculogenic progenitors. Plos One 2008;3:e1652. (Pubitemid 351865455)
28. Kusumbe AP, Mali AM, Bapat SA. CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature. Stem Cells 2009;27:498-508.
29. Mabuchi S, Terai Y, Morishige K et al. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model. Clin Cancer Res 2008;14:7781-7789.